CapsoVision (CV) Cost of Revenue (2024 - 2025)
CapsoVision recorded quarterly Cost of Revenue of $800000.0 in Q4 2025, down 54.88% quarter-over-quarter from $1.8 million in Q3 2025, and down 55.53% year-over-year from $1.8 million in Q4 2024.
CapsoVision's Cost of Revenue history runs 2 years deep, the most recent figure standing at $800000.0 for Q4 2025.
- In Q4 2025, Cost of Revenue fell 55.53% year-over-year to $800000.0; the TTM figure through Dec 2025 stood at $5.9 million (changed N/A YoY), while the FY2025 annual figure was $6.4 million, down 8.41% from the prior year.
- Cost of Revenue came in at $800000.0 for Q4 2025 at CapsoVision, down from $1.8 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $1.8 million in Q4 2024 to a low of $800000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.26 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.51 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 441.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 481.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 891.20 Mn |
| 10 | CapsoVision | 167.59 Mn | 157.48 Mn | 1.95 Mn | 800,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 1.77 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.78 Mn |